JANUS HENDERSON GROUP PLC - Significant Ownership

Signature - Title
Kristin Mariani - Head of North America Compliance
Location
London, United Kingdom
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by JANUS HENDERSON GROUP PLC.

Significant Ownership of JANUS HENDERSON GROUP PLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MNPR MONOPAR THERAPEUTICS INC Common Stock 17.2% $30.9M 1.05M JANUS HENDERSON GROUP PLC Dec 31, 2024
DRUG BRIGHT MINDS BIOSCIENCES INC. Common Stock 16% $40.1M $11M 1.11M +38.1% JANUS HENDERSON GROUP PLC Mar 31, 2025
ETNB 89bio, Inc. Common Stock 15.3% $145M 20.3M JANUS HENDERSON GROUP PLC Jan 31, 2025
AVDL AVADEL PHARMACEUTICALS PLC Common Stock 14.6% $118M 14.1M JANUS HENDERSON GROUP PLC Dec 31, 2024
LXEO Lexeo Therapeutics, Inc. Common Stock 13.1% $11.5M 4.34M JANUS HENDERSON GROUP PLC Dec 31, 2024
CCSI Consensus Cloud Solutions, Inc. Common Stock 12.7% $59.4M 2.45M JANUS HENDERSON GROUP PLC Dec 31, 2024
CMPR Cimpress plc Common Stock 12.1% $128M 3.04M JANUS HENDERSON GROUP PLC Dec 31, 2024
SLNO SOLENO THERAPEUTICS, INC. Common Stock 12% $254M 5.19M JANUS HENDERSON GROUP PLC Dec 31, 2024
TFX TELEFLEX INCORPORATED Common Stock 11.3% $730M 5.26M JANUS HENDERSON GROUP PLC Dec 31, 2024
BNTC BENITEC BIOPHARMA INC. Common Stock 11.3% $34.8M 2.62M JANUS HENDERSON GROUP PLC Dec 31, 2024
MREO Mereo BioPharma Group plc American Depositary Shares 11% $42.8M 17.1M JANUS HENDERSON GROUP PLC Dec 31, 2024
ARDX Ardelyx Inc Common Stock 10.3% $137M 24.4M JANUS HENDERSON GROUP PLC Dec 31, 2024
TARA PROTARA THERAPEUTICS, INC. Common Stock 10.3% $15.4M -$6.76M 3.79M -30.5% JANUS HENDERSON GROUP PLC Feb 28, 2025
WEX WEX Inc. Common Stock 10.2% $609M 4.05M JANUS HENDERSON GROUP PLC Dec 31, 2024
MDGL MADRIGAL PHARMACEUTICALS, INC. Common Stock 10.1% $723M 2.21M JANUS HENDERSON GROUP PLC Dec 31, 2024
LRMR LARIMAR THERAPEUTICS, INC. Common Stock 10.1% $20.8M 6.44M JANUS HENDERSON GROUP PLC Dec 31, 2024
FBRX FORTE BIOSCIENCES, INC. Common Stock 10% $4.14M 691K JANUS HENDERSON GROUP PLC Dec 31, 2024
ICUI ICU MEDICAL, INC. Common Stock 9.9% $335M 2.41M JANUS HENDERSON GROUP PLC Dec 31, 2024
SGRY Surgery Partners, Inc. Common Stock 9.6% $287M 12.1M JANUS HENDERSON GROUP PLC Jan 29, 2025
MIRM Mirum Pharmaceuticals, Inc. Common Stock 9.5% $206M 4.58M JANUS HENDERSON GROUP PLC Dec 31, 2024
LNTH LANTHEUS HOLDINGS, INC. Common Stock 8.9% $625M 6.2M JANUS HENDERSON GROUP PLC Dec 31, 2024
SKIN The Beauty Health Company Common Stock 8.8% $14.9M 11.1M JANUS HENDERSON GROUP PLC Jan 31, 2025
AKRO Akero Therapeutics Inc Common Stock 8.7% $277M 6.03M JANUS HENDERSON GROUP PLC Dec 31, 2024
PCVX VAXCYTE, INC. Common Stock 8.5% $772M 10.6M JANUS HENDERSON GROUP PLC Dec 31, 2024
ZD ZIFF DAVIS, INC. Common Stock 8.2% $142M 3.49M JANUS HENDERSON GROUP PLC Dec 31, 2024
OSIS OSI SYSTEMS, INC. Common Stock 7.4% $216M 1.23M JANUS HENDERSON GROUP PLC Dec 31, 2024
GPCR STRUCTURE THERAPEUTICS INC American Depositary Shares 7.3% $89.1M 4.16M JANUS HENDERSON GROUP PLC Dec 31, 2024
DYN DYNE THERAPEUTICS INC Common Stock 7.3% $88.8M 7.38M JANUS HENDERSON GROUP PLC Dec 31, 2024
ASND Ascendis Pharma A/S American Depositary Shares 7.2% $658M 4.38M JANUS HENDERSON GROUP PLC Dec 31, 2024
BHVN Biohaven Ltd. Common Stock 6.9% $205M 6.98M JANUS HENDERSON GROUP PLC Dec 31, 2024
FLEX FLEX LTD. Ordinary Shares 6.8% $919M 26.5M JANUS HENDERSON GROUP PLC Dec 31, 2024
IDYA IDEAYA Biosciences, Inc. Common Stock 6.8% $108M 5.86M JANUS HENDERSON GROUP PLC Dec 31, 2024
SSNC SS&C TECHNOLOGIES HOLDINGS, INC. Common Stock 6.7% $1.4B 16.6M JANUS HENDERSON GROUP PLC Dec 31, 2024
FWONK LIBERTY MEDIA CORPORATION Series C Liberty Formula One Common Stock 6.5% $1.24B 14.5M JANUS HENDERSON GROUP PLC Dec 31, 2024
ST SENSATA TECHNOLOGIES HOLDING PLC Ordinary Shares 6.5% $258M 9.77M JANUS HENDERSON GROUP PLC Dec 31, 2024
ASUR ASURE SOFTWARE INC Common Stock 6.5% $15.8M 1.71M JANUS HENDERSON GROUP PLC Dec 31, 2024
CRGX CARGO Therapeutics, Inc. Common Stock 6.2% $11.1M 2.83M JANUS HENDERSON GROUP PLC Dec 31, 2024
ARMK ARAMARK Common Stock 6.1% $581M 16.3M JANUS HENDERSON GROUP PLC Dec 31, 2024
JANX JANUX THERAPEUTICS, INC. Common Stock 6.1% $113M 3.56M JANUS HENDERSON GROUP PLC Dec 31, 2024
ZAI LAB LTD American Depositary Shares 6.1% 66.9M JANUS HENDERSON GROUP PLC Dec 31, 2024
RNA AVIDITY BIOSCIENCES, INC. Common Stock 5.9% $233M 7.05M JANUS HENDERSON GROUP PLC Dec 31, 2024
DOX AMDOCS LIMITED Ordinary Shares 5.8% $571M 6.59M JANUS HENDERSON GROUP PLC Dec 31, 2024
GMED GLOBUS MEDICAL, INC. Class A Common Stock 5.8% $472M 6.61M JANUS HENDERSON GROUP PLC Dec 31, 2024
BLKB Blackbaud, Inc. Common Stock 5.7% $192M 2.89M JANUS HENDERSON GROUP PLC Dec 31, 2024
TRDA Entrada Therapeutics, Inc. Common Stock 5.6% $24.8M 2.08M JANUS HENDERSON GROUP PLC Dec 31, 2024
WD Walker & Dunlop, Inc. Common Stock 5.5% $159M 1.85M JANUS HENDERSON GROUP PLC Dec 31, 2024
IMNM IMMUNOME INC Common Stock 5.5% $31.8M 3.46M JANUS HENDERSON GROUP PLC Dec 31, 2024
LGND LIGAND PHARMACEUTICALS INCORPORATED Common Stock 5.4% $110M 1.02M JANUS HENDERSON GROUP PLC Dec 31, 2024
TENX Tenax Therapeutics, Inc Common Stock 5.4% $1.23M 193K JANUS HENDERSON GROUP PLC Dec 31, 2024
Rentokil Initial plc Common Stock 5.3% $677M 135M JANUS HENDERSON GROUP PLC Dec 31, 2024
SXT Sensient Technologies Corporation Common Stock 5.3% $164M 2.26M JANUS HENDERSON GROUP PLC Dec 31, 2024
EWTX EDGEWISE THERAPEUTICS, INC. Common Stock 5.3% $140M 4.98M JANUS HENDERSON GROUP PLC Dec 31, 2024
RVTY REVVITY INC Common Stock 5.2% $718M 6.36M JANUS HENDERSON GROUP PLC Dec 31, 2024
RVMD REVOLUTION MEDICINES, INC. Common Stock 5.2% $372M 9.48M JANUS HENDERSON GROUP PLC Dec 31, 2024
FDMT 4D Molecular Therapeutics, Inc. Common Stock 4.9% $9.32M 2.25M JANUS HENDERSON GROUP PLC Dec 31, 2024
NEO NEOGENOMICS INC Common Stock 4.8% $65M 6.17M JANUS HENDERSON GROUP PLC Dec 31, 2024
CZR CAESARS ENTERTAINMENT INC Common Stock 3.3% $205M 7.1M JANUS HENDERSON GROUP PLC Dec 31, 2024
IMUX Immunic, Inc. Common Stock 3% $3.01M 2.69M JANUS HENDERSON GROUP PLC Dec 31, 2024
PEPG PEPGEN INC Common Stock 1.6% $1.18M 522K JANUS HENDERSON GROUP PLC Dec 31, 2024
CATX PERSPECTIVE THERAPEUTICS INC Common Stock 0% $47.5K 17.8K JANUS HENDERSON GROUP PLC Dec 31, 2024
APLT APPLIED THERAPEUTICS INC Common Stock 0% $17.9K 35.8K JANUS HENDERSON GROUP PLC Dec 31, 2024
NGNE NEUROGENE INC. Common Stock 0% $0 0 JANUS HENDERSON GROUP PLC Dec 31, 2024
CTMX CytomX Therapeutics, Inc. Common Stock 0% $0 0 JANUS HENDERSON GROUP PLC Dec 31, 2024
DTIL Precision BioSciences, Inc. Common Stock 0% $0 0 JANUS HENDERSON GROUP PLC Dec 31, 2024

Schedules 13D/G Reported by JANUS HENDERSON GROUP PLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.